1-20 of 1607
Lymphoid Neoplasia
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Comparative Effectiveness of Bruton Tyrosine Kinase Inhibitors in Relapsed/Refractory Mantle Cell Lymphoma

Open Access
Tycel J. Phillips, Mengyang Di, Taavy Miller, Jingru Wang, Amy Pierre, Gregory A Maglinte, Erlene K Seymour, Yucai Wang
Journal: Blood Advances
Blood Adv bloodadvances.2025017160.
https://doi.org/10.1182/bloodadvances.2025017160
Published: 2025
Includes: Supplemental data
Journal Articles

An analysis of diagnostic metabolomic profiles associated with hepatotoxicity during childhood ALL induction therapy

Open Access
Emily J. Mason, Anna M. Crain, Michael E. Scheurer, Philip J. Lupo, Karen R. Rabin, Olga A. Taylor, Marley Roberts, John P. Woodhouse, Ashley Chavana, Kathleen Ludwig, Laura Klesse, Kenneth Heym, Timothy Griffin, Rodrigo Erana, Juan Carlos Bernini, M. Monica Gramatges, Joanna S. Yi, Sandi L. Pruitt, M. Brooke Bernhardt, Hong Zhu, Steven D. Mittelman, Van Huynh, Etan Orgel, Jeremy M. Schraw, Austin L. Brown
Journal: Blood Advances
Blood Adv (2025) 9 (22): 5802–5810.
https://doi.org/10.1182/bloodadvances.2025016978
Published: 2025
Includes: Supplemental data
Journal Articles

An AI model classifies risks of early relapse post–CAR T-cell therapy in a multicenter real-world population with DLBCL

Open Access
Clinical Trials & Observations
Michelle Wang, Krishna V. Komanduri, Debajyoti Datta, Ayan Patel, Barbee Whitaker, Artur Belov, Benjamin Rubin, Rohit Vashist, Rosa Rodriguez-Monguio, Pelin Cinar, Steven Anderson, Atul J. Butte
Journal: Blood Advances
Blood Adv (2025) 9 (22): 5837–5852.
https://doi.org/10.1182/bloodadvances.2025016375
Published: 2025
Includes: Supplemental data
Journal Articles

Non-DLBCL monomorphic and Hodgkin lymphoma PTLD: clinical insights and treatment strategies

Open Access
Suheil Albert Atallah-Yunes, Arushi Khurana, Thomas M. Habermann
Journal: Blood Advances
Blood Adv (2025) 9 (22): 5792–5801.
https://doi.org/10.1182/bloodadvances.2025016930
Published: 2025
Journal Articles

Artificial intelligence–based flow cytometry for the diagnosis of B-cell chronic lymphoproliferative disorders

Open Access
Laurent Mauvieux, Raoul Herbrecht, Alice Eischen, Anne-Cécile Galoisy, Delphine Rolland, Carine Gervais, Caroline Mayeur-Rousse, Sarah Hueber-Bonnot, Alina Nicolae, Luc-Matthieu Fornecker, Thibaut Goetsch, François Severac, Razvan Bizoï, Thibaut Fabacher, Laurent Miguet
Journal: Blood Advances
Blood Adv (2025) 9 (22): 5880–5887.
https://doi.org/10.1182/bloodadvances.2025016424
Published: 2025
Includes: Supplemental data
Journal Articles

Neighborhood socioeconomic status and overall survival among children with acute lymphoblastic leukemia

Open Access
Clinical Trials & Observations
Anna L. Hoppmann, Deborah M. Hurley, Stuart Cramer, Monique J. Brown, Rahul Ghosal, Anthony J. Alberg, Smita Bhatia
Journal: Blood Advances
Blood Adv (2025) 9 (22): 5861–5869.
https://doi.org/10.1182/bloodadvances.2025017044
Published: 2025
Includes: Supplemental data
Journal Articles

Infections and parameters of humoral immunity with talquetamab in relapsed/refractory multiple myeloma in MonumenTAL-1

Open Access
Clinical Trials & Observations
Carolina Schinke, Paula Rodriguez-Otero, Niels W. C. J. van de Donk, Brea Lipe, Noa Lavi, Leo Rasche, Samir Parekh, Oliver Van Oekelen, Deeksha Vishwamitra, Sheri Skerget, Diana Cortes-Selva, Raluca Verona, Brandi Hilder, Tara Masterson, Michela Campagna, Sheetal Khedkar, Thomas Renaud, Jaszianne Tolbert, Colleen Kane, Kathleen S. Gray, Ibrahim Saber, Christoph Heuck, Ajai Chari
Journal: Blood Advances
Blood Adv (2025) 9 (22): 5752–5762.
https://doi.org/10.1182/bloodadvances.2025016613
Published: 2025
Includes: Supplemental data
Journal Articles

Role of race and ethnicity in survival among children/young adults with relapsed ALL: a Children’s Oncology Group report

Open Access
John A. Ligon, Lingyun Ji, Alice Dang, Xinxin Xu, Susan R. Rheingold, Deepa Bhojwani, Meenakshi Devidas, John A. Kairalla, Mary Shago, Nyla A. Heerema, Andrew J. Carroll, Michael Borowitz, Brent L. Wood, Naomi J. Winick, William L. Carroll, Stephen P. Hunger, Elizabeth A. Raetz, Mignon L. Loh, Sumit Gupta, Lena E. Winestone
Journal: Blood Advances
Blood Adv (2025) 9 (22): 5738–5751.
https://doi.org/10.1182/bloodadvances.2025016670
Published: 2025
Includes: Supplemental data
Journal Articles

Modification of belantamab mafodotin dosing to balance efficacy and tolerability in the DREAMM-7 and DREAMM-8 trials

Open Access
Clinical Trials & Observations
María-Victoria Mateos, Suzanne Trudel, Hang Quach, Paweł Robak, Meral Beksac, Ludek Pour, Marek Hus, Kihyun Kim, Vera Zherebtsova, Sosana Delimpasi, Tomas Jelínek, Christopher Ward, P. Joy Ho, Vladimir Vorobyev, Marcelo Pitombeira de Lacerda, Gracia Aparecida-Martinez, Ivan Spicka, Jakub Radocha, Michele Cavo, Claudio Cerchione, Chengcheng Fu, Kazuhito Suzuki, Rachel Rogers, Amy Phillips-Jones, Zhaohui Wang, Hena Baig, Jodie Wilkes, Xiaoou L. Zhou, Eric Lewis, Lydia Eccersley, Neal Sule, Prani Paka, Joanna B. Opalinska, Pralay Mukhopadhyay, Vania Hungria, Meletios Athanasios Dimopoulos
Journal: Blood Advances
Blood Adv (2025) 9 (22): 5708–5719.
https://doi.org/10.1182/bloodadvances.2025016949
Published: 2025
Includes: Supplemental data
Journal Articles

The CAR-HEMATOTOX: ready for prime time

Open Access
Jan H. Frenking, Kai Rejeski
Journal: Blood Advances
Blood Adv (2025) 9 (21): 5638–5640.
https://doi.org/10.1182/bloodadvances.2025017509
Published: 2025
Journal Articles

Population-based validation of the CAR-HEMATOTOX for hematotoxicity, infections, and survival after CART in R/R LBCL

Open Access
Janneke W. de Boer, Kylie Keijzer, Suzanne van Dorp, Pim G. N. J. Mutsaers, Anne G. H. Niezink, Jaap A. van Doesum, Yasmina I. M. Serroukh, Louise W. Muntendam, Astrid E. Pulles, Esther J. Kret, Aniko Sijs-Szabo, Jesse Oomen, Astrid M. P. Demandt, Wendy B. C. Stevens, Maria T. Kuipers, Elise R. A. Pennings, Anne M. Spanjaart, Marie José Kersten, Margot Jak, Lisanne V. van Dijk, Marjolein W. M. van der Poel, Joost S. P. Vermaat, Tom van Meerten
Journal: Blood Advances
Blood Adv (2025) 9 (21): 5641–5650.
https://doi.org/10.1182/bloodadvances.2025016689
Published: 2025
Includes: Supplemental data
Journal Articles

A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL

Open Access
Clinical Trials & Observations
Kirk Cahill, James Godfrey, Chadi Nabhan, Justin Kline, Peter A. Riedell, Kenneth S. Cohen, Sunil Narula, Theodore G. Karrison, Jessica Robertson, Reem Karmali, Parameswaran Venugopal, Seo-Hyun Kim, Aaron P. Rapoport, Seung Tae Lee, Jennie Law, Paul A. S. Fishkin, Iris Isufi, Mario Velasco, Lynne Kaminer, Sonali M. Smith
Journal: Blood Advances
Blood Adv (2025) 9 (21): 5665–5675.
https://doi.org/10.1182/bloodadvances.2025017092
Published: 2025
Includes: Supplemental data
Journal Articles

Double-Hit Lymphoma: Is Lenalidomide Just Right

Open Access
Clinical Trials & Observations
Jack K. Driml
Journal: Blood Advances
Blood Adv (2025) 9 (21): 5663–5664.
https://doi.org/10.1182/bloodadvances.2025017787
Published: 2025
Journal Articles

Smoldering multiple myeloma in the United States: A population-based analysis

Open Access
Shi-Yi Wang, Rong Wang, Martin Schoen, John H Huber, Eric Feuer, Jennifer Ruhl, Natalia Neparidze, Xiaomei Ma, Amy J Davidoff, Su-Hsin Chang
Journal: Blood Advances
Blood Adv bloodadvances.2025017817.
https://doi.org/10.1182/bloodadvances.2025017817
Published: 2025
Journal Articles

Outcomes for CART as 2L vs 3L vs 4L or Beyond in Aggressive B-cell Lymphoma: Real World Evidence from the ABC Consortium

Open Access
John Seng Wang, Brandon Lee Ellsworth, Megan Melody, Narendranath Epperla, Deborah M Stephens, Jason T. Romancik, Matthew J. Cortese, Rahul S Bhansali, Tamara K Moyo, Vaishalee P Kenkre, Thomas A Ollila, Brian T Hess, Lindsey A. Fitzgerald, Geoffrey Shouse, Matthew J. Matasar, Megan M. Herr, James A Davis, Christy Jesme, Ari Pelcovits, Jonathan Moreira, Adam Yuh Lin, Shuo Ma, Jane N Winter, Alexey V Danilov, Nirav N Shah, Stefan K. Barta, Jonathon B Cohen, Leo I. Gordon, Natalie S. Grover, Reem Karmali
Journal: Blood Advances
Blood Adv bloodadvances.2025017120.
https://doi.org/10.1182/bloodadvances.2025017120
Published: 2025
Includes: Supplemental data
Journal Articles

Diagnostic Criteria for NK-Cell Large Granular Lymphocyte Leukemia: Validation Through a Multicentric International Study

Open Access
Cedric Pastoret, Jun Yang, David J. Feith, Mikael Roussel, Aline Moignet, Shubha Dighe, Micheal Dimitri Solga, Tony Marchand, Garance Visser, Vanessa Rebecca Gasparini, Antonella Teramo, Renato Zambello, Thomas P Loughran, Thierry Lamy
Journal: Blood Advances
Blood Adv bloodadvances.2025016509.
https://doi.org/10.1182/bloodadvances.2025016509
Published: 2025
Includes: Supplemental data
Journal Articles

Nivolumab in combination with R-CHOP for treatment-naïve diffuse large B-cell lymphoma: an evaluation of safety and efficacy

Open Access
Clinical Trials & Observations
Oluwatobi Odetola, Shuo Ma, Jane Winter, Barbara Pro, Ishan Roy, Ping Xie, Bin Zhang, Qing Chen, George P. Koulogeorgas, Xinlei Mi, Ruohui Chen, Yangruijue Ma, Xiaodan Tang, Robert Bayer, Robert Eisner, Valerie Nelson, Habib Shaikh, Dean Tsarwhas, Faisal Saghir, Parameswaran Venugopal, Leo I. Gordon, Reem Karmali
Journal: Blood Advances
Blood Adv (2025) 9 (21): 5616–5625.
https://doi.org/10.1182/bloodadvances.2025016298
Published: 2025
Journal Articles

ctDNA MRD after CAR-T

Open Access
Clinical Trials & Observations
Salvatore Fiorenza, Mark R. Dowling
Journal: Blood Advances
Blood Adv (2025) 9 (21): 5568–5570.
https://doi.org/10.1182/bloodadvances.2025017507
Published: 2025
Journal Articles

After the fog has lifted: infections with CD19 CAR-T therapy

Open Access
Clinical Trials & Observations
Catherine Orla Morrissey
Journal: Blood Advances
Blood Adv (2025) 9 (21): 5510–5511.
https://doi.org/10.1182/bloodadvances.2025017162
Published: 2025
Journal Articles

Routine prophylaxis with levetiracetam offers no benefit in CD19 CAR-T for LBCL: a multicenter propensity-matched study

Open Access
Eugenio Galli, Roberta Di Blasi, Alice Di Rocco, Caterina Cristinelli, Ilaria Pansini, Côme Bommier, Alessandro Corrente, Ilenia De Bernardis, Marcello Viscovo, Stefan Hohaus, Anna Modoni, Federica Sorà, Patrizia Chiusolo, Maurizio Martelli, Simona Sica, Catherine Thieblemont
Journal: Blood Advances
Blood Adv (2025) 9 (21): 5501–5509.
https://doi.org/10.1182/bloodadvances.2025017378
Published: 2025
Includes: Supplemental data